CHICAGO HIGHLIGHTS 2024 – MELANOMA ROUNDTABLE DISCUSSION: Advances in treating advanced melanoma progressing on checkpoint inhibitor therapy

CHICAGO HIGHLIGHTS 2024 – MELANOMA ROUNDTABLE DISCUSSION: Advances in treating advanced melanoma progressing on checkpoint inhibitor therapy

Chicago Highlights 2024 Roundtable Discussions
Icon Chair Speaker

Chair

Dr. Vanessa Bernstein

Icon Chair Speaker

Panelists

Prof. Caroline Robert
Dr. Marcus Butler

Studies/trials discussed:

  • Efficacy and safety of lifileucel, an autologous tumor-infiltrating lymphocyte cell therapy, and pembrolizumab in patients with immune checkpoint inhibitor-naive unresectable or metastatic melanoma: Updated results from IOV-COM-202 cohort 1A.
Tagged